vs
安费诺(APH)与艾默生(EMR)财务数据对比。点击上方公司名可切换其他公司
安费诺的季度营收约是艾默生的1.5倍($6.4B vs $4.3B),安费诺净利率更高(18.6% vs 13.9%,领先4.6%),安费诺同比增速更快(49.1% vs 4.1%),安费诺自由现金流更多($1.5B vs $602.0M),过去两年安费诺的营收复合增速更高(40.6% vs -0.3%)
安费诺是一家总部位于美国的电子零部件制造企业,核心产品涵盖电子连接器、光纤连接器、同轴电缆等各类线缆及互连系统,是全球互连解决方案领域的主流供应商,品牌名称源自其前身American Phenolic Corp的名称缩写组合。
艾默生是总部位于美国密苏里州圣路易斯的世界500强跨国企业,业务涵盖工业自动化设备、暖通控制系统、精密测量仪器的研发制造,同时面向工业、商业、消费级市场提供工程服务及对应软件工程解决方案。
APH vs EMR — 直观对比
营收规模更大
APH
是对方的1.5倍
$4.3B
营收增速更快
APH
高出45.0%
4.1%
净利率更高
APH
高出4.6%
13.9%
自由现金流更多
APH
多$866.5M
$602.0M
两年增速更快
APH
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $6.4B | $4.3B |
| 净利润 | $1.2B | $605.0M |
| 毛利率 | 38.2% | 53.2% |
| 营业利润率 | 26.8% | 17.8% |
| 净利率 | 18.6% | 13.9% |
| 营收同比 | 49.1% | 4.1% |
| 净利润同比 | 60.2% | 3.4% |
| 每股收益(稀释后) | $0.93 | $1.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APH
EMR
| Q4 25 | $6.4B | $4.3B | ||
| Q3 25 | $6.2B | $4.9B | ||
| Q2 25 | $5.7B | $4.6B | ||
| Q1 25 | $4.8B | $4.4B | ||
| Q4 24 | $4.3B | $4.2B | ||
| Q3 24 | $4.0B | $4.6B | ||
| Q2 24 | $3.6B | $4.4B | ||
| Q1 24 | $3.3B | $4.4B |
净利润
APH
EMR
| Q4 25 | $1.2B | $605.0M | ||
| Q3 25 | $1.2B | $637.0M | ||
| Q2 25 | $1.1B | $586.0M | ||
| Q1 25 | $737.8M | $485.0M | ||
| Q4 24 | $746.1M | $585.0M | ||
| Q3 24 | $604.4M | $996.0M | ||
| Q2 24 | $524.8M | $329.0M | ||
| Q1 24 | $548.7M | $501.0M |
毛利率
APH
EMR
| Q4 25 | 38.2% | 53.2% | ||
| Q3 25 | 38.1% | 51.9% | ||
| Q2 25 | 36.3% | 52.6% | ||
| Q1 25 | 34.2% | 53.5% | ||
| Q4 24 | 34.3% | 53.5% | ||
| Q3 24 | 33.6% | 51.3% | ||
| Q2 24 | 33.6% | 52.8% | ||
| Q1 24 | 33.4% | 52.2% |
营业利润率
APH
EMR
| Q4 25 | 26.8% | 17.8% | ||
| Q3 25 | 27.5% | 16.4% | ||
| Q2 25 | 25.1% | 16.1% | ||
| Q1 25 | 21.3% | 14.2% | ||
| Q4 24 | 22.1% | 18.6% | ||
| Q3 24 | 20.3% | 14.7% | ||
| Q2 24 | 19.4% | 10.4% | ||
| Q1 24 | 21.0% | 16.2% |
净利率
APH
EMR
| Q4 25 | 18.6% | 13.9% | ||
| Q3 25 | 20.1% | 13.1% | ||
| Q2 25 | 19.3% | 12.9% | ||
| Q1 25 | 15.3% | 10.9% | ||
| Q4 24 | 17.3% | 14.0% | ||
| Q3 24 | 15.0% | 21.6% | ||
| Q2 24 | 14.5% | 7.5% | ||
| Q1 24 | 16.9% | 11.4% |
每股收益(稀释后)
APH
EMR
| Q4 25 | $0.93 | $1.07 | ||
| Q3 25 | $0.97 | $1.12 | ||
| Q2 25 | $0.86 | $1.04 | ||
| Q1 25 | $0.58 | $0.86 | ||
| Q4 24 | $0.16 | $1.02 | ||
| Q3 24 | $0.48 | $1.74 | ||
| Q2 24 | $0.41 | $0.57 | ||
| Q1 24 | $0.87 | $0.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.4B | — |
| 总债务越低越好 | $14.6B | $7.6B |
| 股东权益账面价值 | $13.4B | $20.3B |
| 总资产 | $36.2B | $41.9B |
| 负债/权益比越低杠杆越低 | 1.09× | 0.37× |
8季度趋势,按日历期对齐
现金及短期投资
APH
EMR
| Q4 25 | $11.4B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $2.0B | — |
总债务
APH
EMR
| Q4 25 | $14.6B | $7.6B | ||
| Q3 25 | $7.1B | $8.9B | ||
| Q2 25 | $7.1B | $8.3B | ||
| Q1 25 | $6.8B | $8.2B | ||
| Q4 24 | $6.5B | $6.6B | ||
| Q3 24 | $5.1B | $7.7B | ||
| Q2 24 | $5.0B | $7.1B | ||
| Q1 24 | $3.6B | $7.6B |
股东权益
APH
EMR
| Q4 25 | $13.4B | $20.3B | ||
| Q3 25 | $12.5B | $20.3B | ||
| Q2 25 | $11.5B | $19.9B | ||
| Q1 25 | $10.3B | $19.2B | ||
| Q4 24 | $9.8B | $20.5B | ||
| Q3 24 | $9.5B | $21.6B | ||
| Q2 24 | $9.0B | $20.8B | ||
| Q1 24 | $8.7B | $20.9B |
总资产
APH
EMR
| Q4 25 | $36.2B | $41.9B | ||
| Q3 25 | $27.1B | $42.0B | ||
| Q2 25 | $25.7B | $42.5B | ||
| Q1 25 | $22.9B | $42.0B | ||
| Q4 24 | $21.4B | $42.6B | ||
| Q3 24 | $19.6B | $44.2B | ||
| Q2 24 | $18.6B | $45.6B | ||
| Q1 24 | $16.7B | $46.4B |
负债/权益比
APH
EMR
| Q4 25 | 1.09× | 0.37× | ||
| Q3 25 | 0.57× | 0.44× | ||
| Q2 25 | 0.62× | 0.42× | ||
| Q1 25 | 0.66× | 0.42× | ||
| Q4 24 | 0.66× | 0.32× | ||
| Q3 24 | 0.54× | 0.36× | ||
| Q2 24 | 0.56× | 0.34× | ||
| Q1 24 | 0.41× | 0.36× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.7B | $699.0M |
| 自由现金流经营现金流 - 资本支出 | $1.5B | $602.0M |
| 自由现金流率自由现金流/营收 | 22.8% | 13.9% |
| 资本支出强度资本支出/营收 | 3.9% | 2.2% |
| 现金转化率经营现金流/净利润 | 1.44× | 1.16× |
| 过去12个月自由现金流最近4个季度 | $4.4B | $4.4B |
8季度趋势,按日历期对齐
经营现金流
APH
EMR
| Q4 25 | $1.7B | $699.0M | ||
| Q3 25 | $1.5B | $3.1B | ||
| Q2 25 | $1.4B | $1.1B | ||
| Q1 25 | $764.9M | $241.0M | ||
| Q4 24 | $847.1M | $777.0M | ||
| Q3 24 | $704.0M | $3.3B | ||
| Q2 24 | $664.1M | $1.1B | ||
| Q1 24 | $599.5M | $743.0M |
自由现金流
APH
EMR
| Q4 25 | $1.5B | $602.0M | ||
| Q3 25 | $1.2B | $2.7B | ||
| Q2 25 | $1.1B | $977.0M | ||
| Q1 25 | $576.3M | $154.0M | ||
| Q4 24 | $647.3M | $694.0M | ||
| Q3 24 | $474.0M | $2.9B | ||
| Q2 24 | $522.8M | $998.0M | ||
| Q1 24 | $505.2M | $661.0M |
自由现金流率
APH
EMR
| Q4 25 | 22.8% | 13.9% | ||
| Q3 25 | 19.6% | 54.9% | ||
| Q2 25 | 19.8% | 21.5% | ||
| Q1 25 | 12.0% | 3.5% | ||
| Q4 24 | 15.0% | 16.6% | ||
| Q3 24 | 11.7% | 63.1% | ||
| Q2 24 | 14.5% | 22.8% | ||
| Q1 24 | 15.5% | 15.1% |
资本支出强度
APH
EMR
| Q4 25 | 3.9% | 2.2% | ||
| Q3 25 | 4.2% | 8.9% | ||
| Q2 25 | 5.3% | 2.0% | ||
| Q1 25 | 3.9% | 2.0% | ||
| Q4 24 | 4.6% | 2.0% | ||
| Q3 24 | 5.7% | 9.1% | ||
| Q2 24 | 3.9% | 2.1% | ||
| Q1 24 | 2.9% | 1.9% |
现金转化率
APH
EMR
| Q4 25 | 1.44× | 1.16× | ||
| Q3 25 | 1.18× | 4.86× | ||
| Q2 25 | 1.30× | 1.83× | ||
| Q1 25 | 1.04× | 0.50× | ||
| Q4 24 | 1.14× | 1.33× | ||
| Q3 24 | 1.16× | 3.35× | ||
| Q2 24 | 1.27× | 3.31× | ||
| Q1 24 | 1.09× | 1.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APH
| Communications Solutions Segment | $3.5B | 54% |
| Harsh Environment Solutions Segment | $1.7B | 26% |
| Sales Channel Through Intermediary | $1.4B | 21% |
EMR
| Other | $1.8B | 41% |
| Software And Systems | $1.0B | 24% |
| Intelligent Devices | $996.0M | 23% |
| Safety And Productivity | $503.0M | 12% |